{9 (3.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection) } Pack — RxCUI 2723916
RxNorm drug concept · Generic pack
RxCUI 2723916
Generic pack · GPCK
● Current RxNorm concept 12 FDA products
12 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2723916
Official name{9 (3.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known asremestemcel-L-rknd Kit Patient Weight 100 - < 112.5 KG
FDA products mapped12
Package NDCs mapped12
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How {9 (3.8 ML remestemcel-L-rknd 6680000 CELLS/ML I... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
{9 (3.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection) } Pack
RxCUI 2723916 Generic pack · GPCK
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Remestemcel-L
2700765IN -
Remestemcel-L-rknd
2700764PIN
-
Remestemcel-L
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Ryoncil
2700773BN
-
Ryoncil
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Remestemcel-L Injection
2700768SCDF -
Remestemcel-L-rknd Injection
2700770SCDFP -
Remestemcel-L Injectable Product
2700767SCDG -
Remestemcel-L-rknd Injectable Product
2700769SCDGP -
Remestemcel-L Injection [Ryoncil]
2700776SBDF -
Remestemcel-L-rknd Injection [Ryoncil]
2700777SBDFP -
Ryoncil Injectable Product
2700775SBDG -
Pack
746839DF - +1 more in this family
-
Remestemcel-L Injection
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
3.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection
2700771SCD -
Remestemcel-L-rknd 6680000 CELLS/ML
2700766SCDC -
3.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection [Ryoncil]
2700778SBD -
Remestemcel-L-rknd 6680000 CELLS/ML [Ryoncil]
2700774SBDC
-
3.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection
-
Packs 1
Fixed collections of drugs packaged and sold together, like dose packs.
Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
3.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection
SCD · 2700771 -
Remestemcel-L-rknd 6680000 CELLS/ML
SCDC · 2700766 -
Remestemcel-L Injection
SCDF · 2700768 -
Remestemcel-L-rknd Injection
SCDFP · 2700770 -
Remestemcel-L Injectable Product
SCDG · 2700767 -
Remestemcel-L-rknd Injectable Product
SCDGP · 2700769
Brand-Name Concepts
-
3.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection [Ryoncil]
SBD · 2700778 -
{9 (3.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection [Ryoncil]) } Pack [Ryoncil Kit 100 - < 112.5 kg]
BPCK · 2723917 -
Remestemcel-L-rknd 6680000 CELLS/ML [Ryoncil]
SBDC · 2700774 -
Remestemcel-L Injection [Ryoncil]
SBDF · 2700776 -
Remestemcel-L-rknd Injection [Ryoncil]
SBDFP · 2700777 -
Ryoncil Injectable Product
SBDG · 2700775 -
Ryoncil
BN · 2700773
📦 FDA Products & Package NDCs
12 products · 12 package NDCs
12 package NDCs map to RxCUI 2723916 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 73648-0111-01 | 1 KIT in 1 CARTON (73648-111-01) * 1 VIAL, PLASTIC in 1 CA... | RYONCIL | Mesoblast | 2025-03-17 |
| 73648-0112-02 | 1 KIT in 1 CARTON (73648-112-02) * 1 VIAL, PLASTIC in 1 CA... | RYONCIL | Mesoblast | 2025-03-17 |
| 73648-0113-03 | 1 KIT in 1 CARTON (73648-113-03) * 1 VIAL, PLASTIC in 1 CA... | RYONCIL | Mesoblast | 2025-03-17 |
| 73648-0114-01 | 1 KIT in 1 CARTON (73648-114-01) * 4 VIAL, PLASTIC in 1 CA... | RYONCIL | Mesoblast | 2025-03-17 |
| 73648-0115-02 | 1 KIT in 1 CARTON (73648-115-02) * 4 VIAL, PLASTIC in 1 CA... | RYONCIL | Mesoblast | 2025-03-17 |
| 73648-0116-03 | 1 KIT in 1 CARTON (73648-116-03) * 4 VIAL, PLASTIC in 1 CA... | RYONCIL | Mesoblast | 2025-03-17 |
| 73648-0117-04 | 1 KIT in 1 CARTON (73648-117-04) * 4 VIAL, PLASTIC in 1 CA... | RYONCIL | Mesoblast | 2025-03-17 |
| 73648-0118-02 | 1 KIT in 1 CARTON (73648-118-02) * 4 VIAL, PLASTIC in 1 CA... | RYONCIL | Mesoblast | 2025-03-17 |
| 73648-0119-03 | 1 KIT in 1 CARTON (73648-119-03) * 4 VIAL, PLASTIC in 1 CA... | RYONCIL | Mesoblast | 2025-09-28 |
| 73648-0120-04 | 1 KIT in 1 CARTON (73648-120-04) * 4 VIAL, PLASTIC in 1 CA... | RYONCIL | Mesoblast | 2025-09-28 |
| 73648-0121-05 | 1 KIT in 1 CARTON (73648-121-05) * 4 VIAL, PLASTIC in 1 CA... | RYONCIL | Mesoblast | 2025-09-28 |
| 73648-0122-03 | 1 KIT in 1 CARTON (73648-122-03) * 4 VIAL, PLASTIC in 1 CA... | RYONCIL | Mesoblast | 2025-09-28 |
Observed labelers:
Mesoblast (12)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J3402 | Inj. remestemcel-l-rknd/ td | 9 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.